期刊文献+

复方大黄对HBV抗原分泌的抑制作用研究 被引量:1

Inhibition of Compound Rhubarb Oral Liquid on HBV Antigen Secretion of HepG2.2.15 Cell Line in Vitro
下载PDF
导出
摘要 目的观察复方大黄对HBV病毒复制的抑制作用。方法用MTT法测定复方大黄在不同浓度下对HepG2.2.15细胞的细胞毒性,ELISA法检测复方大黄对HepG2.2.15细胞分泌HBsAg、HBeAg颗粒的影响。结果复方大黄对HepG2.2.15细胞4 d和8 d的半数毒性浓度(TD50)分别为1.73和1.06(P<0.05);对HBeAg4 d和8 d的治疗指数(TI)分别为2.84和5.30(P<0.01);对HBsAg 4 d和8 d的治疗指数分别为0.00和0.42(P>0.05)。结论复方大黄可抑制HepG2.2.15细胞分泌HBeAg,具有体外抗乙型肝炎病毒的作用。 Objective To observe the effect of compound rhubarb oral liquid on inhibiting HepG2. 2.15 cell secreting HBsAg, HBeAg in vitro. Methods the effect of compound rhubarb oral liquid on inhibiting HepG2.2.15 cell secreting HBsAg, HBeAg were detected by ELISA, and the toxic effect of Compound Rhubarb Oral Liquid of different concentration to HepG2.2.15 cell was determined by MFT. Results The therapy index(TI) of four days and eight days of compound rhu- barb oral liquid to HepG2.2. 15 cell secreting HBsAg were 0.0 and 0.42, respectively (P 〉 0. 05 ), HBeAg were 2.84 and 5.30 , respectively (P 〈0.01 ). 50% toxic density(TD50) of four days and eight days of compound rhubarb oral liquid to HepG2.2.15 cell were 1. 73 and 1.06, respectively (P 〈0.05). Cenclusien Compound rhubarb oral liquid can inhibit HepG2.2.15 cell secreting HBeAg.
出处 《湖北民族学院学报(医学版)》 2008年第1期16-17,共2页 Journal of Hubei Minzu University(Medical Edition)
基金 湖北省教育厅课题(D20069008)
关键词 中药 复方大黄 nepG2.2.15细胞 HBV抗原 Herb Compound rhubarb oral liquid HepG2.2.15 HBV antigen
  • 相关文献

参考文献5

二级参考文献27

  • 1窦晓光.慢性乙型肝炎处理亚太共识(2003年更新版)解读[J].中国实用内科杂志,2004,24(8):463-465. 被引量:6
  • 2病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 3骆抗先.实验感染模型[A].骆抗先主编.乙型肝炎基础和临床:第2版[C].北京:人民卫生出版社,2001.74-84.
  • 4王国俊 蔡雄.氧化苦参碱治疗慢性乙型肝炎的研究总结[J].传染病信息,2001,14:7-7.
  • 5Core Working Party for the Asia-Pacific consensus on hepatitis B,C.Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region.Gastroenterol Hepatol,2000,15(8):825-841
  • 6Lok ASF,McMahon BJ.Chronic hepatitis B.Hepatology,2001,34(6):1225-1241
  • 7Liaw YF,Tasi SL.Pathogenesis and clinical significance of acute exacerbation and remissions in patients with chronic hepatitis B virus infection.Viral Hep Rev,1997,3(1):143-154
  • 8Hsu YS,Chien RN,Yeh CT,et al.Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.Hepatology,2002,35(6):1522-1527
  • 9Kao JH.Hepatitis B viral genotypes:clinical relevance and molecular characteristics.Gastroenterol Hepatol,2002,17(4):643-650
  • 10Lai MY,Cooksley WGE,Piravisuth T et al.Efficacy and safety of peginterferon alfa-2A(40KD)(PEGASYS)in HBeAg-positive chronic hepatitis B(CHB):48-week results from a phase Ⅱstudy.Gastroenterol Hepatol,2002,17(Suppl):A27

共引文献38

同被引文献22

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部